Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses S Elisaf

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Expert Opinion on Drug Safety|May 9, 2012
Nicotinic acid: clinical considerationsAnastazia Kei, Moses S Elisaf
World Journal of Nephrology|November 1, 2013
Proton pump inhibitor-induced hypomagnesemia: A new challengeMatilda Florentin, Moses S Elisaf
Expert Opinion on Drug Safety|March 16, 2012
Simvastatin interactions with other drugsMatilda Florentin, Moses S Elisaf
Angiology|May 14, 2010
Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece surveyMoses S Elisaf, Nikos Nikas
Current Vascular Pharmacology|May 1, 2013
Recommendations for severe hypertriglyceridemia treatment, are there new strategies?Theodosios D Filippatos, Moses S Elisaf
Current Cardiology Reports|April 23, 2017
Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?Evangelos C Rizos, Moses S Elisaf
Expert Opinion on Drug Safety|July 3, 2015
Safety considerations with fenofibrate/simvastatin combinationTheodosios D Filippatos, Moses S Elisaf
Expert Opinion on Pharmacotherapy|September 8, 2005
Therapeutic management of hyperglycaemic hyperosmolar syndromeHaralampos J Milionis, Moses S Elisaf
World Journal of Hepatology|November 8, 2011
Role of ezetimibe in non-alcoholic fatty liver diseaseTheodosios D Filippatos, Moses S Elisaf
World Journal of Cardiology|July 29, 2014
Antihypertensive drugs and glucose metabolismChristos V Rizos, Moses S Elisaf
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Expert Opinion on Drug Safety|May 9, 2012
Nicotinic acid: clinical considerationsAnastazia Kei, Moses S Elisaf
World Journal of Nephrology|November 1, 2013
Proton pump inhibitor-induced hypomagnesemia: A new challengeMatilda Florentin, Moses S Elisaf
Expert Opinion on Drug Safety|March 16, 2012
Simvastatin interactions with other drugsMatilda Florentin, Moses S Elisaf
Angiology|May 14, 2010
Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece surveyMoses S Elisaf, Nikos Nikas
Current Vascular Pharmacology|May 1, 2013
Recommendations for severe hypertriglyceridemia treatment, are there new strategies?Theodosios D Filippatos, Moses S Elisaf
Current Cardiology Reports|April 23, 2017
Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?Evangelos C Rizos, Moses S Elisaf
Expert Opinion on Drug Safety|July 3, 2015
Safety considerations with fenofibrate/simvastatin combinationTheodosios D Filippatos, Moses S Elisaf
Expert Opinion on Pharmacotherapy|September 8, 2005
Therapeutic management of hyperglycaemic hyperosmolar syndromeHaralampos J Milionis, Moses S Elisaf
World Journal of Hepatology|November 8, 2011
Role of ezetimibe in non-alcoholic fatty liver diseaseTheodosios D Filippatos, Moses S Elisaf
World Journal of Cardiology|July 29, 2014
Antihypertensive drugs and glucose metabolismChristos V Rizos, Moses S Elisaf
Pageof 20